The SWOG S1011 randomized phase 3 trial found no significant improvement in disease-free or overall survival but a higher rate of grade 3-4 adverse events and an increased risk of death in the 90 days after surgery.
UK opens vaccine centre to bolster pandemic preparedness
The facility will deal with activities throughout the lifecycle of a vaccine, from product design to assessment of effectiveness. Credit: Mongkolchon Akesin / Shutterstock.com. The
August 7, 2023